Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 5,470.00
-60.00 (-1.08%)
At close: Oct 2, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 72.66 billion as of October 2, 2026. Its market cap has decreased by -20.49% in one year.
Market Cap
72.66B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
64.57
Stock Price
5,470.00
ChartMarket Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 72.66B, an increase of 575.91%. That is a compound annual growth rate of 8.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 72.66B | -12.20% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DongKoo Bio & Pharma | 95.05B |
| H.PIO | 87.34B |
| Samik Pharmaceutical Company LTD. | 86.08B |
| Sam-A Pharm. | 84.53B |
| Daehan Nupharm | 78.46B |
| Pharos iBio | 77.93B |
| Sinil Pharmaceutical | 73.72B |
| Sinsin Pharmaceutical | 67.58B |